Grapheal is a leading brand in the field of biosensors, offering flexible and connected solutions for wearables and field monitoring. Their innovative products, such as GraphLAB and TestNpass, provide continuous monitoring and diagnostics for wound care and in vitro diagnostics. Grapheal's biosensors are designed to be embedded in wearables, making them easily accessible and user-friendly.

With the ability to dose biomarkers and detect pathogens, these digital biosensors offer fast and accurate detection capabilities. What sets Grapheal apart is that their biosensors are powered and operated by smartphones, eliminating the need for dedicated readers. Furthermore, Grapheal prioritizes e-health connectivity and interoperability.

Their biosensors connect and aggregate new biomarker data to the emerging medical Cloud, facilitating efficient data management and analysis. Grapheal's mission is supported by a network of partners and supporters who recognize the brand's commitment to revolutionizing healthcare. With their cutting-edge technology and dedication to innovation, Grapheal is shaping the future of biosensing